Synergistic Nanomedicines: Integrating Chemotherapy and Phototherapy for Enhanced Cancer Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 558
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are pleased to invite submissions for a Special Issue titled "Synergistic Nanomedicines: Integrating Chemotherapy and Phototherapy for Enhanced Cancer Treatment". This Special Issue aims to explore the intersection of nanotechnology and cancer research, focusing on innovative approaches that combine chemotherapy with photothermal therapy to improve treatment efficacy.
Nanomedicine has revolutionized cancer treatment by offering precise drug delivery systems while minimizing side effects. The integration of chemotherapy and photothermal therapy presents a promising strategy to target cancer cells more effectively, enhancing patient outcomes. This Special Issue will highlight the latest advancements in the design, synthesis, and application of nanomaterials for this synergistic treatment approach.
We welcome contributions covering a wide range of topics, including but not limited to the following:
- Novel nanomedicine formulations for chemo-photothermal therapy;
- Mechanistic studies on the synergistic effects of combined therapies;
- Preclinical and clinical studies demonstrating enhanced treatment efficacy.
We look forward to your valuable contributions to this rapidly growing field.
Dr. Nasrin Hooshmand
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterial
- nanomedicine
- chemo-photothermal therapy
- cancer
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
